Etidronate Disodium Tablets
Function and Efficacy
This product is a bone resorption inhibitor. At low doses, it inhibits osteoclast activity, prevents bone resorption, and reduces bone turnover rate to achieve bone calcium regulation.
Ingredients
The main ingredient of this product is sodium etidronate, whose chemical name is disodium 1-hydroxyethyl-1,1-diphosphonate, molecular formula is C2H6Na2O7P2, and molecular weight is 249.99. This product is a white tablet.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Etidronate disodiumIngredients |
This product is a bone resorption inhibitor. At low doses, it inhibits osteoclast activity, prevents bone resorption, and reduces bone turnover rate to achieve bone calcium regulation. More |
7414-83-7 | 9 |
Appearance
This product is white tablets.
Indication
1. Primary osteoporosis, postmenopausal osteoporosis, and drug-induced osteoporosis. 2. Heterotopic ossification such as Paget's disease, osteoarthritis deformans, kidney stones, progressive osteomyositis, and dermatosis. 3. Malignant hypercalcemia (including those caused by tumor metastasis). 4. Surgery of hip joints, spine, etc.
Usage and Dosage
Oral administration, 0.2 g each time, twice a day, between meals.
Adverse Reactions
Symptoms include abdominal discomfort, diarrhea, soft stools, vomiting, stomatitis, headache, burning sensation in the throat, itchy skin, and rash.
Precautions
It is contraindicated for patients with severe renal impairment and osteomalacia.
Special Population Medication
Precautions for children: It may affect bone growth. There have been reports of rickets-like symptoms caused by long-term use. It should be used with caution. Precautions for pregnancy and lactation: Animal experiments have found that high doses can cause fetal bone abnormalities, and the drug can enter breast milk. Therefore, pregnant women and women who may become pregnant should not use it. Precautions for the elderly: Reduce the dosage appropriately.
Drug Interactions
1. Antacids and cathartics often contain calcium or other metal ions such as magnesium and iron, which may affect the absorption of this drug. 2. Combination with aminoglycosides may induce hypocalcemia.
Storage
Seal and store in a cool and dark place. The shelf life is tentatively three years.
Packaging Specification
0.2 g
Validity Period
36 months
Manufacturer
CHIA TAI Tianqing Pharmaceutical Group Co., Ltd.
-
Founded in:
1997-04-16 -
Address:
No. 369, Yuzhou South Road, Lianyungang City, Jiangsu Province -
Tax NO.:
91320000608398264T -
Registered Funds:
890 million yuan -
Website:
-
Email: